Sequent Scientific informs about disclosure

13 Jul 2020 Evaluate

Sequent Scientific has informed that the exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1) (a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agnus Holdings.

The above information is a part of company’s filings submitted to BSE.


Sequent Scientific Share Price

201.70 9.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.